Total Payments
$685.96
2022 Payments
$93.95
Companies
10
Transactions
18
Medicare Patients
1,361
Medicare Billing
$216,573
Payment Breakdown by Category
Food & Beverage$358.96 (52.3%)
Other$250.00 (36.4%)
Education$77.00 (11.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $358.96 | 16 | 52.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 1 | 36.4% |
| Education | $77.00 | 1 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $250.00 | 1 | $0 (2018) |
| UCB, Inc. | $131.71 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $77.00 | 1 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $49.62 | 1 | $0 (2021) |
| GENZYME CORPORATION | $41.73 | 2 | $0 (2020) |
| Lilly USA, LLC | $41.72 | 2 | $0 (2020) |
| Allergan, Inc. | $32.40 | 2 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $26.05 | 1 | $0 (2020) |
| Upsher-Smith Laboratories LLC | $20.17 | 1 | $0 (2020) |
| CSL Behring | $15.56 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $93.95 | 2 | AstraZeneca Pharmaceuticals LP ($77.00) |
| 2021 | $100.55 | 3 | UCB, Inc. ($50.93) |
| 2020 | $209.16 | 10 | UCB, Inc. ($63.83) |
| 2019 | $16.74 | 1 | GENZYME CORPORATION ($16.74) |
| 2018 | $250.00 | 1 | Stryker Corporation ($250.00) |
| 2017 | $15.56 | 1 | CSL Behring ($15.56) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/24/2022 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $77.00 | General |
| 02/09/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Neurology | ||||||
| 09/28/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Neurology | ||||||
| 07/29/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Neurology | ||||||
| 03/04/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $49.62 | General |
| Category: PRIMARY CARE | ||||||
| 11/11/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neurology | ||||||
| 10/22/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2020 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: NEUROLOGY | ||||||
| 08/26/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Neuroscience | ||||||
| 08/19/2020 | Upsher-Smith Laboratories LLC | TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug), ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION, QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROLOGY | ||||||
| 08/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Neuroscience | ||||||
| 02/19/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Neurology | ||||||
| 02/12/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neurology | ||||||
| 01/22/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Neurology | ||||||
| 10/28/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/31/2018 | Stryker Corporation | TREVO (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: MICROCATHETERSTENTRIEVER | ||||||
| 11/15/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 348 | 469 | $76,919 | $40,671 |
| 2022 | 6 | 354 | 525 | $96,789 | $53,625 |
| 2021 | 5 | 215 | 354 | $70,710 | $40,314 |
| 2020 | 8 | 444 | 678 | $127,665 | $81,964 |
Total Patients
1,361
Total Services
2,026
Medicare Billing
$216,573
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 141 | 224 | $24,438 | $14,374 | 58.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 60 | $17,880 | $8,473 | 47.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 54 | $11,130 | $5,723 | 51.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 29 | $11,794 | $5,070 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 51 | $8,584 | $4,923 | 57.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 38 | 51 | $3,093 | $2,109 | 68.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 56 | 126 | $46,620 | $22,300 | 47.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 133 | 202 | $17,574 | $11,592 | 66.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 89 | $15,575 | $9,549 | 61.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 74 | $9,620 | $6,107 | 63.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $3,600 | $2,325 | 64.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 19 | 19 | $3,800 | $1,753 | 46.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 44 | 115 | $41,670 | $21,483 | 51.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 135 | $11,635 | $8,041 | 69.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 57 | 59 | $10,325 | $6,737 | 65.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 25 | $3,080 | $2,156 | 70.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 20 | 20 | $4,000 | $1,898 | 47.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 61 | 145 | $50,750 | $27,625 | 54.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 118 | 228 | $27,360 | $19,769 | 72.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 111 | 114 | $25,650 | $19,220 | 74.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $8,740 | $5,553 | 63.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 89 | $7,565 | $5,466 | 72.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 27 | $2,700 | $1,619 | 59.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 15 | $2,100 | $1,367 | 65.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 14 | 14 | $2,800 | $1,344 | 48.0% |
About Dr. Omran Kaskar, DO
Dr. Omran Kaskar, DO is a Vascular Neurology healthcare provider based in Ypsilanti, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1629208798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omran Kaskar, DO has received a total of $685.96 in payments from pharmaceutical and medical device companies, with $93.95 received in 2022. These payments were reported across 18 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($358.96).
As a Medicare-enrolled provider, Kaskar has provided services to 1,361 Medicare beneficiaries, totaling 2,026 services with total Medicare billing of $216,573. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Vascular Neurology
- Other Specialties Vascular Neurology
- Location Ypsilanti, MI
- Active Since 07/22/2009
- Last Updated 01/19/2024
- Taxonomy Code 2084V0102X
- Entity Type Individual
- NPI Number 1629208798
Products in Payments
- TREVO (Device) $250.00
- Briviact (Drug) $131.71
- NURTEC ODT (Drug) $49.62
- AUBAGIO (Drug) $41.73
- EMGALITY (Drug) $41.72
- UBRELVY (Drug) $32.40
- ONGENTYS (Drug) $26.05
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $20.17
- Kcentra (Biological) $15.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.